Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Summary: Tesamorelin vs Sermorelin at a Glance

Tesamorelin and sermorelin are both GHRH analogs that engage the GHRH-R and stimulate GH secretion in preclinical research models, but they represent meaningfully different research tools. Tesamorelin's full 44-amino acid sequence and N-terminal stabilizing mo

This comparison does not assign a generated winner or score.

  • Tesamorelin and sermorelin are both GHRH analogs that engage the GHRH-R and stimulate GH secretion in preclinical research models, but they represent meaningfully different research tools. Tesamorelin's full 44-amino acid sequence and N-terminal stabilizing modification give it greater resistance to DPP-IV degradation and more sustained receptor engagement than sermorelin's shorter, unmodified 29-amino acid fragment. The right choice for any lab depends on the experimental question: studies requiring sustained GHRH signaling favor tesamorelin, while studies specifically investigating short-duration GHRH activity or truncated GHRH fragment biology may favor sermorelin.
More references

Related material